What is the appropriate management for an 18‑year‑old with persistent asthma who had an exacerbation five months ago, continues to wheeze and experience dyspnea, is using Advair (fluticasone/salmeterol) and nightly naproxen, has nocturnal vomiting, and spirometry showing severely reduced lung volumes (~275–325 mL) at a height of 5′4″?

Immediate Management of Severe Uncontrolled Asthma with Nocturnal Symptoms

This patient requires urgent escalation to Step 5 or 6 therapy with high-dose ICS-LABA combination, immediate assessment for oral corticosteroid burst, and investigation of the nocturnal vomiting which may indicate GERD-triggered asthma or medication side effects. 1, 2

Critical Assessment of Current Situation

Spirometry Values Indicate Severe Impairment

• The reported values of 275-325 mL are critically abnormal for an 18-year-old at 5'4" height—expected peak expiratory flow should be approximately 450-550 L/min (not mL), suggesting either severe obstruction or measurement error 2
• If these represent FEV1 values in liters (0.275-0.325 L), this indicates life-threatening airway obstruction requiring immediate emergency evaluation 3
• Persistent wheezing and dyspnea 5 months post-exacerbation with current controller therapy demonstrates inadequate asthma control 1, 2

Nocturnal Vomiting Requires Investigation

• Naproxen use at night may be causing gastric irritation leading to vomiting, which can trigger bronchospasm 2
• GERD is a common asthma trigger and comorbidity that worsens nocturnal symptoms 2
• Discontinue naproxen immediately and evaluate for GERD as an asthma trigger 2

Immediate Treatment Escalation

Step Up to High-Dose ICS-LABA

• Current Advair dose is insufficient given persistent symptoms—increase to high-dose fluticasone/salmeterol (500 mcg/50 mcg twice daily for adults) 1, 2
• High-dose ICS-LABA is the preferred Step 5 treatment for severe persistent asthma with daily symptoms and nocturnal awakenings 1, 2
• Combination therapy reduces exacerbations by 40% for mild exacerbations and 29% for severe exacerbations compared to ICS alone 4

Consider Oral Corticosteroid Burst

• Persistent symptoms 5 months after exacerbation with severe spirometry values warrant oral prednisone 40-60 mg daily for 5-7 days 3
• Increasing SABA use or persistent symptoms despite controller therapy indicates need for systemic corticosteroids 1, 3

Verify Inhaler Technique and Adherence

• Check inhaler technique at this visit—this is the primary cause of treatment failure 2
• Use MDI with large volume spacer to improve lung delivery and reduce oropharyngeal deposition 2
• Instruct patient to rinse mouth after each ICS use to prevent oral candidiasis 2

Address Nocturnal Symptoms

Eliminate NSAID Trigger

• Stop naproxen immediately—NSAIDs can worsen asthma and cause gastric irritation leading to reflux 2
• If pain control needed, use acetaminophen instead 2

Evaluate and Treat GERD

• Nocturnal vomiting strongly suggests GERD, which triggers nocturnal asthma symptoms 2
• Initiate proton pump inhibitor therapy (omeprazole 20-40 mg daily) 2
• Recommend lifestyle modifications: elevate head of bed, avoid eating 3 hours before bedtime 2

Monitoring and Follow-Up Plan

Short-Term Reassessment (2-4 Weeks)

• Repeat spirometry to verify improvement and ensure accurate baseline measurement 2, 3
• Target FEV1 improvement to 60-80% of predicted values before considering stable 3
• Assess symptom control: nocturnal awakenings, SABA use frequency, activity limitation 1, 2

Provide Written Asthma Action Plan

• Detail when to increase SABA use (up to 3 treatments at 20-minute intervals for acute symptoms) 1
• Specify when to seek emergency care: no improvement after 3 SABA treatments, inability to speak in full sentences, oxygen saturation <90% 3
• Include instructions for self-initiated oral corticosteroid burst if symptoms worsen 3

Consider Specialist Referral

• Consult pulmonology or asthma specialist given Step 5 therapy requirement and persistent severe symptoms 1
• Evaluate for biologic therapy (omalizumab, mepolizumab) if patient remains uncontrolled on high-dose ICS-LABA 1

Critical Pitfalls to Avoid

• Do not continue current inadequate therapy—persistent symptoms for 5 months indicate treatment failure requiring immediate escalation 1, 2
• Do not ignore the nocturnal vomiting—this may be both a trigger and consequence of poor asthma control 2
• Do not assume spirometry values are accurate without verification—the reported values are either life-threatening or measurement error 2, 3
• Do not use LABA as monotherapy—always combine with ICS due to increased risk of severe exacerbations and asthma-related deaths 2